Ignite Creation Date:
2025-12-26 @ 11:07 AM
Ignite Modification Date:
2025-12-29 @ 4:30 AM
Study NCT ID:
NCT00781612
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-24
First Post:
2008-10-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
Sponsor:
Genentech, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-10-16
Start Date Type:
ACTUAL
Primary Completion Date:
2029-09-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-04-30
Completion Date Type:
ESTIMATED
First Submit Date:
2008-10-27
First Submit QC Date:
None
Study First Post Date:
2008-10-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-23
Last Update Post Date:
2025-12-24
Last Update Post Date Type:
ACTUAL